Key facts
- Notable investors include Alpaca VC, Informed Ventures, VitalStage Ventures, Cross Atlantic Angels, Mike Mahlkow — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Autopoiesis Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Autopoiesis Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Autopoiesis Sciences
Developer of an artificial intelligence-based co-scientist designed to accelerate breakthroughs in scientific discovery and therapeutic development. The company offers advanced, self-learning architectures that specialize in scientific tasks, leveraging cloud computing infrastructure for secure, rapid processing of datasets, enabling global researchers and institutions to push the boundaries of human health and innovation.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 11
- Website
- autopoiesis.science/
- Ownership
- Privately Held (backing)
Autopoiesis Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Autopoiesis Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Autopoiesis Sciences in its N-PORT filings yet. We sweep new filings monthly.